New York, NY · Founded 2014 · Privately Held (backing)
Developer of a healthcare device designed to reduce sympathetic nerve activity and address the root cause of heart failure. Axon Therapies is based in New York, NY and was founded in 2014. It was valued at $44.5 million at its later-stage round in Jan 2021, the last priced event on record. It has raised $75.8 million across 3 recorded rounds; the latest was a $7.5 million early-stage round in Jan 2019.
PMV mark · valuation
$44.5M
Oct 2026
Priced at
its later-stage round
Jan 2021
Total raised
$75.8M
Last round
Early Stage VC
Jan 2019
Cap table — not yet on record
Axon Therapies's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Axon Therapies with a free account
·Watch Axon Therapies: the Monday email on marks, rounds and moves
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Axon Therapies's 3 recorded funding rounds.
